Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 65%
filed 2026-06-12
Item 8.01
Bank of New York Mellon announced redemption of 5,825 shares of Series H Noncumulative Perpetual Preferred Stock and corresponding depositary shares on June 20, 2026. While preferred stock redemptions are routine capital management actions for large financial institutions, the disclosure of a specific redemption date and share count in an 8-K Item 8.01 suggests the company deemed this material enough to report. This does not fit cleanly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or litigation), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Item 8.01
The company announced a full redemption of all outstanding Series A and Series B Cumulative Perpetual Preferred Stock (984,000 and 1,760.5 shares respectively) at $25.00 per share plus accrued dividends, effective July 14, 2026, which will eliminate the preferred equity class and delist the preferred shares from Nasdaq.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-12
Item 5.03
ERock amended its Certificate of Incorporation and Bylaws in connection with the IPO, implementing material modifications to the rights of security holders and corporate governance structure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Company deposited $12,203.33 into its Trust Account to extend the business combination deadline from June 13, 2026 to July 13, 2026. This is a material event for a SPAC (special purpose acquisition company) as it directly affects the timeline for completing a business combination and the risk of liquidation. While this does not fit neatly into the standard taxonomy categories (it is neither a completed M&A transaction, a going-concern disclosure, nor a delisting notice), the extension of the business combination deadline is material to investors' assessment of the Company's ability to consummate its stated purpose.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 1.01
Centurion Acquisition Corp. entered into Non-Redemption Agreements with shareholders on June 11, 2026, whereby investors commit not to redeem 4,675,000 Class A shares and to vote in favor of an Extension Amendment Proposal to extend the business combination deadline from June 12, 2026 to June 12, 2027. In exchange, the Sponsor agrees to transfer 1,558,333 Class A shares to these investors. While this is a material definitive agreement affecting shareholder voting and capital structure, it does not fit cleanly into the more specific event categories (it is not M&A activity, an executive change, compensation, or a covenant breach), making "other_material" the most appropriate classification for this shareholder lock-up arrangement tied to a deadline extension vote.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
This disclosure reports the consummation of a $230 million IPO and concurrent $6 million private placement of warrants by a SPAC (special purpose acquisition company). While the IPO itself is a material capital-raising event affecting the registrant's financial position, it does not fit cleanly into the standard 8-K taxonomy—it is neither a traditional earnings release, M&A activity, nor a dilutive issuance in the sense of a distressed equity raise. The event is material to investors but best classified as "other_material" given the SPAC structure and the combination of public and private securities offerings.
View raw filing on EDGAR →
6-K
Other material
confidence 75%
filed 2026-06-12
EX-99.1
Pampa Energía discloses an upgrade of its long-term foreign and local currency credit ratings from "B-" to "B" with stable outlook by S&P. While this is a material event affecting investor perception of the company's creditworthiness and financial condition, it does not fit neatly into the specific financial event categories (debt_issuance, covenant_breach, material_impairment, etc.). The rating upgrade is a financial event but represents a positive development in the company's credit profile rather than a discrete transaction or accounting matter, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 1.02
The filing discloses termination of an Equity Distribution Agreement (Sales Agreement) dated July 28, 2023, which provided for up to $450 million in aggregate gross sales of common stock through sales agents and forward sellers. While the termination itself is routine (triggered by expiration of the underlying shelf registration), the agreement's material size and the company's loss of this financing flexibility warrant disclosure. The termination is not a covenant breach, M&A activity, or other more specific event type, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-12
Item 5.02
Item 5.02 incorporates Item 1.01 by reference, indicating material changes to executive roles, compensation, or governance in connection with the merger and change of control, though the specific nature of these changes cannot be determined without access to the full Item 1.01 disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Nasdaq imposed a trading halt under Code T12 on June 8, 2026, triggering the board to establish a special committee of independent directors to investigate unusual trading activities. While the company states it is unaware of material undisclosed developments, the trading halt itself and the formal investigation response constitute a material event affecting investor confidence and trading ability. This does not fit neatly into delisting_risk (no notice of delisting), but represents a significant trading disruption warranting disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-12
The filing discloses announcement of initial cash dividends on the Company's 9.50% Series A Perpetual Preferred Stock via press release under Item 7.01 (Regulation FD Disclosure). While dividend announcements are routine for mature companies, the initiation of dividends on preferred stock—particularly at a 9.50% rate—signals capital structure changes and cash distribution policy that would be material to investors assessing the registrant's financial position and capital allocation strategy. However, the lack of detail in the 8-K body itself (the actual press release is attached as an exhibit) and the use of Item 7.01 (rather than a more specific Item) creates some ambiguity about whether this is a routine preferred dividend announcement or a more significant capital event.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-06-12
Item 5.03
Wheeler Real Estate Investment Trust, Inc. implemented a one-for-four reverse stock split effective June 17, 2026, via amendments to the Company's charter filed with Maryland. This material modification to the rights of security holders affects share structure, trading mechanics, and conversion terms for convertible securities and preferred stock.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-12
Item 7.01
The filing discloses conclusion of a "strategic review process" via press release on June 12, 2026, but the Item 7.01 disclosure provides no substantive detail about the outcome, recommendations, or implications. Without access to Exhibit 99.1, the specific nature of the strategic review conclusion cannot be determined—it could relate to M&A activity, asset sales, operational restructuring, or other material corporate actions. The materiality and event classification depend critically on the press release content, which is referenced but not excerpted in the Item itself.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-12
Item 7.01
HPS Corporate Lending Fund discloses a letter regarding its second quarter 2026 tender offer under Regulation FD. While tender offers can be material to shareholders (affecting liquidity and valuation), this disclosure is limited to furnishing a letter without substantive detail in the 8-K itself. The event does not fit neatly into standard categories (not M&A, not exec-related, not financial restatement), making "other_material" the most appropriate classification, though the materiality assessment reflects uncertainty about the tender offer's significance without seeing the full letter.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Fund discloses preliminary results of a tender offer for approximately 4.7% of outstanding common shares (2,280,500 shares) that expired June 8, 2026, with purchase price based on NAV as of June 30, 2026. While share repurchases are routine for closed-end funds, a tender offer affecting nearly 5% of shares is a material capital allocation event that would affect investor assessment of the Fund's capital structure and share count. This does not fit neatly into the specific taxonomy categories (not M&A, not dilutive issuance, not a routine administrative matter), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-12
Item 2.02
The filing discloses a dividend declaration on common stock and Series B Preferred Shares via press release under Item 2.02 (Results of Operations and Financial Condition). While dividend declarations are material corporate actions affecting shareholder value, this disclosure does not fit the earnings_release category (which typically reports quarterly/annual financial results) nor any other specific event type. The material nature of dividend declarations to investors warrants classification as other_material rather than a routine administrative disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Item 8.01
This disclosure reports the monthly NAV per share for Rithm Perpetual Life Residential Trust as of May 31, 2026, broken down by share class (Class J at $20.1602 and Class E at $20.2647) with detailed asset and liability components. While NAV reporting is routine for closed-end funds and trusts, the disclosure of current NAV per share is material to investors in assessing the fund's value and performance. However, this does not fit neatly into the more specific event categories (it is not an earnings release, impairment, restatement, or other discrete corporate action), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Item 8.01
The company announced a quarterly cash dividend of $2.00 per share, representing a material capital allocation decision affecting shareholder returns.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-06-12
Item 8.01
Forbright completed its initial public offering on June 11, 2026, issuing 7.9 million shares at $18.00 per share for approximately $142.2 million in gross proceeds, and simultaneously amended and restated its certificate of incorporation and bylaws to establish the capital structure and governance framework for the newly public company.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-06-12
Item 1.01
HF Foods adopted a shareholder rights plan (poison pill) on June 12, 2026, with one Right per share exercisable at $9.55 per one one-thousandth of a share of Series AA Participating Preferred Stock. The plan is triggered by any person or group acquiring 15% or more of Common Stock without Board approval and is designed to deter hostile takeovers by imposing a significant penalty on such acquirers.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The company disclosed interim responder analysis data from a Phase 3 clinical trial (CAPTIVATE) for claseprubart in CIDP via an updated corporate presentation posted to its investor relations website. While clinical trial data updates can be material to investors evaluating the company's pipeline and regulatory prospects, this disclosure does not fit neatly into the more specific event categories (e.g., it is not a formal earnings release, M&A activity, or executive change). The interim nature and presentation format suggest this is a material clinical milestone, warranting classification as other_material rather than forcing it into an ill-fitting category.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 2.03
The Company issued an unsecured promissory note of $191,475 to its sponsor to fund a trust account extension, creating a direct financial obligation with conditional forgiveness and conversion rights that affects the Company's capital structure and timeline for completing its initial business combination.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Company extended its Business Combination Deadline from June 13, 2026 to July 13, 2026 for its merger with MicroTouch Technology Inc., a governance action that materially affects the transaction timeline and likelihood of consummation.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Item 5.03
Aeries Technology effected a 1-for-8 reverse share consolidation through an amendment to its Articles of Association, reducing outstanding Class A ordinary shares from approximately 45.9 million to 5.7 million. In connection with this capital structure change, the Company adjusted warrant terms by reducing the shares issuable per warrant to 1/8th and increasing the exercise price eight-fold to $92.00 per share.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
The filing discloses entry into material definitive agreements on June 9, 2026: a Second Amended and Restated Trust Agreement and an Amended and Restated Sponsor Agreement. While Item 1.01 nominally covers M&A activity, these agreements fundamentally restructure the Trust's governance and compensation arrangements, particularly by authorizing staking programs and directing all staking rewards to the Sponsor outside the Trust's NAV. This is a material governance and economic restructuring affecting shareholder interests, but does not fit cleanly into the M&A taxonomy (no acquisition, merger, or disposition). The event is material to investors as it alters the economic terms and control structure of the ETF.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Fund's Board of Trustees renewed an open-market share repurchase program authorizing purchases of up to 5% of outstanding common shares through June 30, 2027. While share repurchase programs are material to investors as they affect share count, capital allocation, and potential accretion/dilution, this disclosure does not fit neatly into the more specific event categories (it is neither a dilutive issuance, executive compensation, nor M&A activity). The renewal of a repurchase authorization is a governance and capital allocation decision material to shareholders but best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-12
Item 8.01
The Fund's Board of Trustees renewed an open-market share repurchase program authorizing purchases of up to 5% of outstanding common shares through June 30, 2027. While share repurchase programs are routine for closed-end funds seeking to manage discount-to-NAV dynamics, the renewal and authorization of a material repurchase capacity (5% of shares) would affect investor assessment of capital allocation and share price support. This does not fit neatly into the more specific event categories but represents a material corporate action disclosed under Item 8.01.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-12
Item 8.01
The Fund's Board of Trustees renewed an open-market share repurchase program authorizing purchases of up to 5% of outstanding common shares through June 30, 2027. While share repurchase programs are routine for closed-end funds seeking to manage discount-to-NAV dynamics, the renewal and authorization of a material repurchase capacity (5% of shares) would be material to investors assessing capital allocation and potential accretion/dilution. This does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or litigation), so "other_material" is most appropriate.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-11
Item 7.01
Service Corporation International announced an increase to its share repurchase program by approximately $472 million, bringing total authorization to $600 million. While share repurchase programs are material to investors as they signal management's confidence in valuation and affect capital allocation, this disclosure does not fit neatly into the standard taxonomy categories (it is neither a dilutive issuance, M&A activity, nor executive compensation). The announcement reflects a significant capital allocation decision that would affect a reasonable investor's assessment of the company's financial strategy and shareholder returns.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-11
Item 8.01
The filing discloses publication of a notice of an extraordinary general meeting of shareholders on June 11, 2026. While the Item 8.01 disclosure itself is minimal and does not specify the agenda or purpose of the meeting, an extraordinary (non-routine) shareholder meeting typically signals a material corporate event such as a major transaction, governance change, or other significant matter requiring shareholder approval. Without access to the attached exhibit detailing the meeting agenda, the most appropriate classification is "other_material" rather than a more specific event type.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-11
Item 8.01
Bion extended a Memorandum of Understanding with Kimmeridge Energy Management for six months, preserving a Right of First Refusal (ROFR) that was originally granted in December 2025. While the extension itself is contractual in nature, the preservation of ROFR rights—which typically grant preferential acquisition or investment opportunities—could materially affect the company's strategic options and capital structure. The disclosure does not fit neatly into more specific categories (not M&A activity per se, not a financing event, not a routine administrative matter), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-06-11
Item 8.01
Terra Property Trust disclosed an extension of its previously announced Exchange Offer for senior notes maturing June 30, 2026, along with detailed cash flow projections for April–September 2026 revealing a potential liquidity shortfall depending on the exchange offer's success and timing of asset monetizations. The disclosure reflects material concerns about the company's near-term liquidity, ability to meet debt obligations, and dependence on the exchange offer and asset sales to address upcoming maturities.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 8.01
Theriva Biologics announced publication of Phase 1 clinical trial results for VCN-01 in head and neck squamous cell carcinoma (HNSCC), including median progression-free survival and overall survival data, biomarker findings, and mechanistic insights. These clinical results are material to investor assessment of the company's pipeline and the program's viability.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 3.03
The company completed a redomestication from Delaware to Texas, approved by stockholders at the May 8, 2026 Annual Meeting, resulting in a material modification to shareholder rights due to the shift from Delaware law to Texas law governance. The redomestication did not change business operations, headquarters, management, or obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 5.03
The company effected a charter amendment implementing a name change, a material event affecting the registrant's corporate identity and public recognition. The name change was formally announced in the company's press release.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-11
Item 7.01
Caterpillar announced a quarterly cash dividend increase from $1.51 to $1.63 per share, representing an approximately 8% increase that signals management confidence in cash generation.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-11
Item 8.01
Vireo Growth Inc. announced and implemented a 30-for-1 share consolidation effective June 5, 2026, following shareholder approval and Board authorization. This material capital structure reorganization affects all shareholders' ownership percentages and voting rights.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 1.01
AECOM entered into a $500 million revolving credit facility with Bank of America on June 10, 2026, secured with leverage covenants including a 4.00x consolidated leverage ratio. This material financing arrangement affects the company's liquidity, financial flexibility, and capital structure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 8.01
OraSure announced FDA clearance of its Colli-Pee™ Dx Urine Collection Kit for use with Roche molecular diagnostic systems to detect four sexually transmitted infections. This is a material regulatory milestone that expands the company's product portfolio and market reach through a partnership with a major diagnostics company (Roche), but does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, or litigation). The disclosure warrants classification as a material product/regulatory event under "other_material."
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-11
Item 2.03
The filing discloses creation of a direct financial obligation under Item 2.03, incorporating Item 1.01 by reference; the specific nature of the obligation (debt, lease, contingent liability, or other commitment) cannot be determined without access to the referenced Item 1.01 content.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-11
Item 3.03
Item 3.03 discloses a material modification to rights of security holders, incorporating by reference Items 3.01, 5.01, and 5.03; the specific nature of the modification cannot be reliably determined from the cross-references alone, though it likely relates to the merger, delisting, or change of control.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 8.01
This disclosure announces initial Phase 1b clinical trial data for budoprutug in primary ITP, showing favorable safety and efficacy signals (90% B-cell depletion, platelet responses in 4/6 patients at 250 mg dose, no serious adverse events). While clinical trial progress is material to a biotech company's valuation and investor assessment, it does not fit neatly into the standard 8-K event taxonomy (not an earnings release, M&A activity, restatement, or other defined categories). The data supports continued development and is clearly significant to investors, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-11
Item 8.01
Silence Therapeutics disclosed Phase 1 clinical trial data for divesiran (SANRECO study) presented at the EHA 2026 Annual Congress. While this is a clinical development update rather than a traditional earnings release or defined material event, the presentation of follow-up and quality-of-life data from a first-in-class siRNA therapy in a rare disease indication (polycythemia vera) would be material to investors evaluating the company's pipeline and clinical progress. The disclosure does not fit neatly into earnings_release, material_litigation, or other specific categories, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 74%
filed 2026-06-11
Item 8.01
Enliven Therapeutics announced updated positive Phase 1 clinical trial data from the ENABLE trial evaluating ELVN-001 in patients with chronic myeloid leukemia, including key outcomes from an FDA End-of-Phase 1 meeting and selection of the 80 mg QD dose for Phase 3 development. This represents material clinical progress for the company's lead candidate that affects investor assessment of the pipeline and regulatory pathway.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 5.03
The company filed a Series P Certificate of Designation establishing the terms of a new preferred stock class with 8% annual dividends, liquidation preferences, mandatory and optional redemption provisions, and anti-dilution protections. These structural provisions create contingent obligations that could materially affect the company's capital structure and shareholder value.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 8.01
Broadcom announced the launch of cash tender offers for certain debt securities on June 11, 2026. While this is a material capital management activity that would affect investor assessment of the company's financial strategy and debt structure, it does not fit neatly into the more specific event categories (it is not a restatement, auditor change, going concern, impairment, delisting risk, bankruptcy, covenant breach, cybersecurity incident, or dilutive equity issuance). Debt tender offers are material refinancing activities but lack a dedicated taxonomy category, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-11
Item 2.03
This Item 2.03 disclosure reports the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of Pittsburgh. While the filing explicitly states "consolidated obligations issuance is material to the FHLBank," the disclosure is primarily informational and regulatory in nature—it describes the mechanism and structure of consolidated obligations rather than disclosing a specific new debt issuance event. The prose emphasizes that Schedule A lists obligations "committed to be issued" and notes the FHLBank has not made materiality judgments on particular obligations. This appears to be a standing disclosure of the FHLBank's debt issuance framework rather than a discrete material event triggering Item 2.03, making it best classified as other_material rather than a more specific event type.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-06-11
Item 1.01
Badger Meter amended and extended its $150 million revolving credit facility, with a new maturity date of July 8, 2031. The amendment represents a material refinancing and extension of the company's existing credit facilities, affecting its capital structure and liquidity position.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 8.01
General Motors Financial Company closed a $1 billion public offering of senior notes due 2031 with net proceeds of approximately $993 million. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the standard 8-K taxonomy—it is neither a merger/acquisition (ma_activity), a dilutive equity issuance (dilutive_issuance), nor a debt covenant breach (covenant_breach). The disclosure is a routine debt offering, which is material to investors but lacks the specific event-type indicators that would classify it as earnings_release, going_concern, or other defined categories.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-11
Item 8.01
Intuit issued $1.75 billion in aggregate principal amount of senior notes ($750M due 2031 at 4.950% and $1B due 2036 at 5.500%), with net proceeds of approximately $1.74 billion intended for general corporate purposes including potential refinancing of existing debt. While this is a material financing event affecting the registrant's capital structure and liquidity, it does not fit cleanly into the more specific event categories (not a dilutive equity issuance, not M&A activity, not a covenant breach or going-concern disclosure). The disclosure is routine debt issuance disclosure under Item 8.01, making "other_material" the most appropriate classification.
View raw filing on EDGAR →